Arrowhead Research | ARWR - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xencor USD 29.3M 7.49M 2025-12